The response of pre-osteoblasts and osteoclasts to gallium containing mesoporous bioactive glasses. by Gómez-Cerezo, Natividad et al.
Accepted Manuscript
Full length article
The response of pre-osteoblasts and osteoclasts to gallium containing mesopo-
rous bioactive glasses
N. Gómez-Cerezo, E. Verron, V. Montouillout, F. Fayon, P. Lagadec, J.M.
Bouler, B. Bujoli, D. Arcos, M. Vallet-Regí
PII: S1742-7061(18)30382-9
DOI: https://doi.org/10.1016/j.actbio.2018.06.036
Reference: ACTBIO 5546
To appear in: Acta Biomaterialia
Received Date: 23 March 2018
Revised Date: 11 June 2018
Accepted Date: 28 June 2018
Please cite this article as: Gómez-Cerezo, N., Verron, E., Montouillout, V., Fayon, F., Lagadec, P., Bouler, J.M.,
Bujoli, B., Arcos, D., Vallet-Regí, M., The response of pre-osteoblasts and osteoclasts to gallium containing
mesoporous bioactive glasses, Acta Biomaterialia (2018), doi: https://doi.org/10.1016/j.actbio.2018.06.036
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers
we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and
review of the resulting proof before it is published in its final form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
  
1 
 
The response of pre-osteoblasts and osteoclasts to gallium 
containing mesoporous bioactive glasses 
N. Gómez-Cerezo
1,2
, E. Verron
3
, V. Montouillout
4
, F. Fayon
4
, P. Lagadec
5
, J.M. Bouler
3
, B. Bujoli
3
, D. 
Arcos
1,2,*
, M. Vallet-Regí
1,2,*
.  
1. Departamento de Química en Ciencias Farmacéuticas, Facultad de Farmacia, Universidad 
Complutense de Madrid, Instituto de Investigación Sanitaria Hospital 12 de Octubre i+12, Plaza 
Ramón y Cajal s/n, 28040 Madrid, Spain 
2. CIBER de Bioingeniería Biomateriales y Nanomedicina (CIBER-BBN), Spain 
3. Université de Nantes, CNRS, UMR 6230, CEISAM, UFR Sciences et Techniques, 2 Rue de la 
Houssinière, 44322 NANTES Cedex 3, France. 
4. CNRS, UPR 3079, CEMHTI, 1D Avenue de la Recherche Scientifique, 45071 Orléans Cedex 02, 
France. 
5. Université Côte d’Azur, CNRS, Inserm, institut de Biologie Valrose (iBV), 28 Av. de 
Valombrose, 06107 Nice cedex 2, France 
 
*Corresponding authors 
E-mail address : arcosd@ucm.es (Daniel Arcos), vallet@ucm.es (María Vallet-Regí) 
 
  
  
2 
 
Abstract 
Mesoporous bioactive glasses (MBGs) in the system SiO2-CaO-P2O5-Ga2O3 have been synthesized 
by the evaporation induced self-assembly method and subsequent impregnation with Ga cations. 
Two different compositions have been prepared and the local environment of Ga(III) has been 
characterized using 
29
Si, 
71
Ga and 
31
P NMR analysis, demonstrating that Ga(III) is efficiently 
incorporated as both, network former (GaO4 units) and network modifier (GaO6 units). In vitro 
bioactivity tests evidenced that Ga-containing MBGs retain their capability for nucleation and 
growth of an apatite-like layer in contact with a simulated body fluid with ion concentrations nearly 
equal to those of human blood plasma. Finally, in vitro cell culture tests evidenced that Ga 
incorporation results in a selective effect on osteoblasts and osteoclasts. Indeed, the presence of this 
element enhances the early differentiation towards osteoblast phenotype while disturbing 
osteoclastogenesis. Considering these results, Ga-doped MBGs might be proposed as bone 
substitutes, especially in osteoporosis scenarios. 
 
Keywords: gallium, mesoporous bioactive glasses, osteoblast, osteoclast, osteoporosis  
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1. Introduction 
Mesoporous bioactive glasses (MBGs) are a kind of bioceramics with potential application for 
bone tissue regeneration purposes. Since Yan et al prepared MBGs for the first time in 2004[1], these 
materials have arisen great interest in the field of regenerative medicine of bone due to their excellent 
bioactive properties, which have been demonstrated both in vitro [2,3] and in vivo[4,5]. MBGs are 
commonly synthesized in the ternary SiO2-CaO-P2O5 system, with similar chemical compositions to 
those used for conventional bioactive sol-gel glasses [2,6,7]. However, the incorporation of a 
structure directing agent during the hydrolysis and condensation processes leads to the formation of a 
mesophase, which eventually results into ordered mesoporous structures with very high surface areas 
and porosities[8]. The bone regeneration properties of bioglasses come up from their capability to 
exchange ions with the surrounding fluids, mainly Ca
2+
 by H
+
, with the subsequent growth of an 
apatite-like phase on the surface, similar to the mineral component of bones and teeth[9]. Besides, 
the dissolution products of bioactive glasses (Ca
2+
 and silica species in solution) elicit the 
upregulation of pro-osteoblastic genes [10–12] thus enhancing their osteogenic potential.  
The high surface area and porosity of MBGs accelerate the chemical reactions at the implants 
surface and, consequently, MBGs exhibit the fastest bioactive behaviour observed so far in the field 
of bioceramics [13]. The ordered mesoporous structure of MBGs brings about their potential 
applications as drug delivery systems [14] and are excellent matrixes to host and release active 
agents such as antibiotics [15], antiosteoporotics [16] or antitumoral drugs [17], which can even be 
released in a stimuli-responsive manner [18,19].   
The efficiency of MBGs to trigger the ionic exchange with the surrounding fluids has recently 
fostered their application as carriers of therapeutic ions. In this way species, such as Li
+
, Sr
2+
, Cu
2+
 
Co
2+
 or B
3+
 have been incorporated into SiO2-CaO-P2O5 MBGs, with the aim of providing 
osteogenic, cementogenic, angiogenic and antibacterial properties [20] [21–24]. The release of these 
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chemical species can yield very interesting synergies with the bioactive behaviour of MBGs and the 
pharmacological treatment loaded in the mesopores. Therapeutic ions are commonly incorporated to 
MBGs as inorganic salts dissolved together with the MBGs precursors. At the end of the synthesis 
these ions can stay in the MBGs associated to phosphates or as network modifiers of the silica 
matrix, similarly to the role played by calcium cations [25–29] . In most cases, the large volume 
and/or the polarization capacity of these ions are so intense that even low concentrations lead to the 
disorganization of the mesoporous structure [30].  
One of the most interesting therapeutic ions in the field of bone pathologies is Ga (III). The 
inhibition of bone resorption driven by Ga (III) has been widely reported [31–35]. Ga reduces the 
resorption activity, differentiation and formation of osteoclasts without cytotoxic effects in a dose-
dependent manner, pointing out an excellent potential for the treatment of osteoporotic bone 
fractures associated to bone implants [36,37]. In this sense, Ga ions have been successfully combined 
with apatitic calcium phosphate cements and tested both in vitro and in vivo [38]. 
Although some studies have been carried out describing the effects of Ga
3+
 on the structure of 
MBGs [39–42], as well as haemostatic and antibacterial effects [43] , from the best of our knowledge 
no study has considered the effects of Ga containing MBGs on bone cells, such as osteoblasts or 
osteoclasts. This is quite surprising considering the very interesting synergy between Ga
3+
 and 
MBGs for the treatment of osteoporotic bone fractures. Moreover, contrarily to monovalent or 
divalent Cu(II), Co (II), Sr (II), Li (I), etc. cations, which act as modifiers of the silica network when 
incorporated into MBGs, Ga (III) cations can act as both network formers (NF) and network modifier 
(NM). The distribution and local environment of Ga species into MBGs are still poorly understood 
and the influence of Ga on bone remodelling cannot be explained without understanding the 
relationship between the local structure of this inhibitor of bone resorption with the resulting 
biological response.  
  
5 
 
In this paper we evaluate for the first time the biological response of Ga doped MBGs with 
respect to bone forming cells (osteoblasts) and bone resorptive cells (osteoclasts), together with a 
deep study of the local environment of this cation into the mesoporous matrix of these bioceramics. 
2. Materials and methods 
2.1 Synthesis of materials  
Two different MBGs in the system SiO2-CaO-P2O5 were synthetized by evaporation induced 
self-assembly (EISA) method [44] . For this aim, triblock copolymer F127 (EO)100-(PO)65-(EO) was 
used as structure directing agent. Tetraethyl orthosilicate (TEOS) (98%), triethyl phosphate (TEP) 
(99%) and calcium nitrate tetrahydrate Ca(NO3)2·4H2O (99%) were used as SiO2, P2O5 and CaO 
sources, respectively. In a typical synthesis 2 g of surfactant were dissolved in ethanol with HCl 0,5 
M solution at room temperature. Afterward TEOS, TEP and Ca(NO3)2·4H2O were added under 
stirring in 3 hours intervals to obtain two different MBG denoted MBG-58S and MBG-85S. The 
different reagents and amounts are shown in Table 1. The resulting solution was kept under stirring 
for 12 hours and poured into Petri dishes (9 cm in diameter). The colourless solution was evaporated 
at 30ºC for 7 days. Eventually, the dried gels were removed as homogeneous and transparent 
membranes and calcined at 700ºC for 3 hours under air atmosphere. 
Solids MBG-58SGa and MBG-85SGa were synthetized from MBG-58S and MBG-85S 
respectively. In a typical procedure, a certain amount of Ga(NO3)3·4H2O was dissolved in a vessel 
containing 100 mL of ultrapure water. Then 500 mg of the corresponding MBG (MBG-58S or MBG-
85S) were added to the solution in such a way that the Ga/Ca molar ratio was 0.38 (see Table 1). The 
pH of the solution was adjusted in the 9.2-9.8 range by means of a concentrated ammonia solution. 
The mixture was stirred for 24 hours at room temperature and the solids obtained were filtered under 
vacuum. Finally, solids were dried at 100ºC for 24 hours. All reactants were purchased from Aldrich 
and used without further purification. 
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2.2 Physicochemical characterization of MBGs 
Low angle powder X-ray diffraction experiments were performed with a Philips X’Pert 
diffractometer equipped with Cu K radiation (wavelength 1.5406 Å). XRD patterns were collected 
in the 2θ° range between 0,5 and 6,5 with a step size of 0.02 2θ° and counting time of 4s per step. 
The textural properties of the calcined materials were determined by nitrogen adsorption with a 
Micromeritics ASAP 2010 equipment. To perform the N2 adsorption measurements, the samples 
were previously degassed under vacuum for 20 h, at 100 ºC. The surface area was determined using 
the Brunauer-Emmett-Teller (BET) method. The pore size distribution between 0.5 and 40 nm was 
determined from the adsorption branch of the isotherm by means of the Barret-Joyner-Halenda 
(BJH) method. This experiment was made in triplicate using different batches of each sample. 
Chemical compositions of MBGs were determined by X-ray fluorescence (XRF) spectroscopy, 
using a Philips PANalytical AXIOS spectrometer (Philips Electronics NV), with X-rays generated by 
the RhKα line at λ = 0.614 Å. 
29
Si MAS and {
1
H}-
29
Si CP-MAS NMR spectra were recorded on a Bruker Avance 400WB 
spectrometer operating at a magnetic field of 9.4 T (
29
Si Larmor frequency of 79.5MHz) at a 
spinning frequency of 12 kHz. The 29Si quantitative MAS spectra were acquired using a 90° flip 
angle with a recycling delay of 5s and around 10000 scans were co-added. The {
1
H}-
29
Si CP-MAS 
spectra were recorded using a contact time of 3.5 ms. 135000 transients were co-added with a recycle 
delay of 5s. The 
71
Ga NMR experiments were performed on a Bruker Avance III spectrometer 
operating at 20.0 T (
71
Ga Larmor frequency of 259.3MHz) equipped with a 1.3mm double-resonance 
MAS probe head. The 
71
Ga central transition (CT)-selective MAS spectra were recorded using a 
Hahn echo sequence with whole echo acquisition. The echo delay was synchronized with the rotor 
period and the rf-field strength was 60 kHz corresponding to a CT-selective /2 pulse of 2.1 s. 
Approximately, 28 000 transients were accumulated for MBG-58SGa and 122 500 for MBG-85SGa 
with 0.5 s recycling delay. The 
31
P quantitative MAS spectra were recorded using single pulse (/10) 
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acquisition; ~500 scans were co-added with a recycle delay of 120 s to ensure complete recovering 
of the longitudinal magnetization. 
1
H SPINAL-64 decoupling with a nutation frequency of 70 kHz 
was applied during signal acquisition[45]. Chemical shift values were referenced to tetramethylsilane 
(TMS), H3PO4 and Ga(NO3)3.4H2O for 
29
Si, 
31
P and 
71
Ga, respectively 
Transmission electron microscopy (TEM) was carried out using a JEOL-2100 microscope, 
operating at 300 kV (Cs 0.6 mm, resolution 1.7 Å). Images were recorded using a CCD camera 
(model Keen view, SIS analyses size 1024 x 1024, pixel size 23.5 mm x 23.5mm) at 30000x and 
60000x magnification using a low-dose condition. 
2.3 In vitro bioactivity tests  
Assessments of in vitro bioactivity were carried out on powder samples. For this purpose, 50 mg 
of powder were soaked into 7 mL of filtered simulated body fluid (SBF), in polyethylene containers 
at 37 ºC under sterile conditions. SBF solution was prepared according to Kokubo et al. [46] by 
dissolving NaCl, KCl, NaHCO3, K2HPO4·3H2O, MgCl2·6H2O, CaCl2, and Na2SO4 into distilled 
water. It was buffered at pH = 7.38 by using tris(hydroxymethyl)-aminomethane/HCl (TRIS/HCl) 
and then passed through 0.22 μm Millipore filters to avoid bacterial contamination. To avoid false 
positive responses, we included -Al2O3 as inert control (Fig S5 in supporting information). The 
evolution of the glass surface was analysed by Fourier transform infrared (FTIR) spectroscopy with a 
Nicolet Magma IR 550 spectrometer and by scanning electron microscopy (SEM) using a JEOL F-
6335 microscope. To assess the Ca
2+
-H
+
 ionic exchange between MBGs and SFB, calcium 
concentration and pH changes were analysed as a function of soaking time by using an Ilyte Na
+
 K
+
 
Ca
2+
 pH system. All the experiments were carried out in triplicate 
2.4 Ga in vitro release 
Ga release study was performed suspending 2 mg of solids in 2 mL of -MEM (Sigma Chemical 
Company, St. Louis, MO, USA). 0.5 mL of this suspension was placed on a transwell permeable 
support with polycarbonate membrane (0.4 lm). The well was filled with 1.5 mL of MEM and the 
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suspension was stirred at 37 C at 100 rpm for 10 days. The amount of Ga released was determined by 
inductively coupled plasma spectroscopy (ICP), and the solution outside the transwell insert was 
replaced with fresh medium after each measurement. All the experiments were carried out in 
triplicate. 
2.5 Pre-osteoblast cell culture tests 
Murine MC3T3-E1 pre-osteoblasts (2·10
4
 cell/mL) were cultured in α-MEM with 10% fetal 
bovine serum (FBS, Gibco, BRL), 1 mM L-glutamine (BioWhittaker Europe, Belgium), penicillin 
(200 mg∙mL-1, BioWhittaker Europe, Belgium), and streptomycin (200 mg∙mL-1), BioWhittaker 
Europe, Belgium), under a CO2 (5%) atmosphere at 37 ºC for 12 hours to reach the confluence in 
each cell plate. After that the MBGs powders were added on the cells at 1mg/ml of concentration.  
2.5.1 Fluorescence microscopy assays. 
To evaluate cells morphology after 4 days in contact with the materials, MC3T3-E1 cells were 
cultured in 24 well plates at density of 10
4
 cells/mL in the presence of 1mg/mL of the different 
MBGs. Thereafter, cells were rinsed with PBS twice and fixed in 4% (w/v) paraformaldehyde in 
PBS for 2 hours.  The samples were incubated 15 min with Atto 565-conjugated phalloidin (dilution 
1:40, Molecular Probes) which stains actin filaments. Samples were then washed with PBS and the 
cell nuclei were stained with lM40-6 diamino-20-phenylindole in PBS (DAPI) (Molecular Probes). 
Fluorescence microscopy was performed with an Evos FL Cell Imaging System equipped with tree 
Led Lights Cubes (lEX (nm); lEM (nm)): DAPY (357/44; 447/60), GFP (470/22; 525/50), RFP 
(531/40; 593/40) from AMG (Advance Microscopy Group). Red channel was used to evaluate the 
cytoskeleton and blue for cell nucleus. All the experiments were carried out in triplicate. 
2.5.2 Pre-osteoblast proliferation studies 
The proliferation was determined by means of the Alamarblue® method at 1, 4, and 7 days of culture 
in contact with the different samples. The Alamarblue® method is based on the reduction of blue 
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fluorogen (resazurin) to a red fluorescent compound (resofurin) by intracellular redox enzymes. A 
solution of resazurin sodium salt (Sigma Aldrich) at 0.01 mg/mL was prepared in phosphate-buffered 
saline (PBS) and then diluted 1:10 with culture medium supplemented with 10 % FBS. The cells 
were exposed to resazurin solution for 3 h at 37° C under CO2 (5 %) atmosphere. Then fluorescence 
signal was read at λem=590 nm using a λexc= 560nm with a fluorescence spectrometer Biotek Synergy 
4 device. Thereafter, the medium was renewed to continue the cell proliferation measurements at 
different times. Polystyrene culture plate was used as control and all the experiments were carried 
out in n = 4. 
2.5.3 Pre-Osteoblasts early differentiation studies 
The alkaline phosphatase (ALP) activity after 7 days in the presence of 1mg/mL of the MBGs, 
was measured to evaluate the influence of the Ga as a differentiation marker in assessing the 
expression of the osteoblast phenotype. For this purpose, 3·10
4
 MC3T3-E1 cells were seeded with a 
1 mg/mL using supplemented medium with -glycerolphosphate (50 mg mL-1, Sigma Chemical 
Company, St. Louis, MO, USA) and L-ascorbic acid (10 mM, Sigma Chemical Company, St. Louis, 
MO, USA). Solids were irrigated with PBS two times to remove as much residual serum possible. 
The cells were detached by subjecting the plates to cycles of freezing and thawing before measuring 
the ALP activity and total protein content. ALP activity was measured based on the hydrolysis of p-
nitrophenylphosphate to p-nitrophenol. After 30 min incubation at 37ºC the reaction was stopped by 
the addition of 125 L of 2M NaOH. The solution obtained was measured using a Helios Zeta UV-
VIS spectrophotometer at 410 nm. Total protein content was determined using a colorimetric method 
at 540 nm (Bio-Analítica,S.L.) with a Helios Zeta UV-VIS spectrophotometer. Polystyrene culture 
plate was used as control and all the experiments were carried out in triplicate. 
2.6 Osteoclasts culture tests 
  
10 
 
The mouse monocyte cell line RAW 264.7 was obtained from ATCC (Ref. # TIB-71; LGC 
Standards, Molsheim, France). Cells were cultured in Dulbecco’s Modified Eagle’s Medium 
(DMEM, Gibco, Paisley, UK) containing 5% Hyclone serum (Thermo Scientific Braunschweig, 
Germany) and 1% penicillin/streptomycin (Gibco, Paisley, UK). For osteoclast differentiation 
experiments, RAW 264.7 cells were seeded at 5,000 cells/cm
2 
in alpha Minimum Essential Medium 
(α-MEM, Gibco, Paisley, UK) containing 5% Hyclone serum and effectors were added immediately. 
RANKL (Receptor Activator of Nuclear Factor- B Ligand) was used at 20 nM. Mouse effector GST-
RANKL was produced as described by Strazic et al [47], and a GST protein was produced and 
purified using the same protocol and was used as a control. Cells were cultured for four days with a 
renewal of the medium at day 2.  
2.6.1 Viability assay 
Raw 264.7 cells were seeded at a density of 5000 cells/cm
2
 and treated with the different MBGs 
at 10mg/mL or culture medium as control. After 4 days of incubation, the cells were incubated in a 
solution of 3-(4.5-dimethylthiazol-2-yl)-2.5-diphenyltetrazoliumbromide (MTT) at 0.5mg/mL for 4h. 
Then, the MTT solution was removed and replace by the same amount of the eluting buffer 
(DMSO/Ethanol 50:50). After 2h agitation on an orbital shaker, 80µl of the colourful supernatant 
were transferred into a new 96-well plate which was read at 562 nm. 
2.6.2 Tartrate-resistant acid phosphatase (ACP5) staining 
Raw 264.7 cells were seeded as previously described and treated with the different types of MBGs 
(10mg/mL) for 4 days. For control, cells were cultured without MBG. After 4 days, cells were rinsed 
two times in PBS and fixed in citrate/acetone solution for 30 s. ACP5
+
 cells were revealed using the 
Acid Phosphatase, Leukocyte kit following manufacturer’s instructions (# 387A; Sigma-Aldrich, 
USA). Stained cells were observed using a light microscope (Axioplan 2, Zeiss, Germany) and the number of 
TRAP-positive multinucleated cells was evaluated by comparing 8 fields between the different treatments. To 
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further quantify the TRAP staining, DMSO was added, and the plate was centrifuged for 15 min at 150 rpm at 
room temperature in dark. Finally, optical density at 562 nm was read [47]. 
Statistical analysis  
The statistics data are expressed as means-standard deviations of experiments. Statistical analysis 
was performed using the Statistical Package for the Social Sciences (SPSS) version 11.5 software. 
Statistical comparisons were made by analysis of variance (ANOVA). Subsequently, post hoc 
analyses were carried out to correct for multiple comparisons. In all the statistical evaluations, P < 
0.05 was considered as statistically significant. 
3. Results 
3.1 Physicochemical characterization of MBGs 
The mesoporous structure of the MBGs was studied by XRD and TEM (Figure 1). Both studies 
showed a disordered mesoporous structure for MBG-58S and MBG-58SGa materials, as usually 
found for MBGs with high calcium content. On the contrary, MBG-85S and MBG-85SGa exhibit a 
highly ordered hexagonal structure with planar group p6mm and parallel channels with a d-spacing 
of 5-6 nm, similarly to the silica mesoporous material SBA-15 [48]. To obtain a deeper knowledge of 
the mesoporous structure, textural properties were analyzed by N2 adsorption/desorption method. All 
the curves could be identified as type IV isotherms characteristic of mesoporous materials (Figure S1 
in supporting information). Surface areas, pore volumes and pore sizes of the four MBGs are 
collected in Table 2. Gallium-free MBGs show surface areas and pore volumes of in the range 
commonly observed for MBGs when prepared with F127 as structure directing agent [8]. After Ga 
incorporation, a decrease of surface area and pore volume is observed for both compositions (MBG-
58SGa and MBG-85SGa). Regarding pore size, Ga incorporation comprises a significant increment 
of this parameter for MBG-58SGa. On the contrary, pore size remains almost constant for MBG-85S 
after Ga incorporation.  
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The chemical compositions of the MBGs are shown in Table 3. The incorporation of Ga
3+
 was 
carried out based on an ionic exchange with Ca
2+
 and the theoretical values displayed in Table 3 
correspond to this assumption.  The results obtained by XRF elemental analysis demonstrate that Ga 
incorporates to the MBGs in a very efficient way. In the case of MBG-58SGa, Ga incorporation is 
associated with a calcium loosening respect to MBG-58S, in agreement with the assumed mechanism 
that involved a Ca
2+ 
versus
 
Ga
3+
 ionic exchange. On the other hand, Ga incorporation within MBG-
85SGa did not result in a significant calcium decrease.  
To study the local atomic environment in the MBGs and the effect of Ga incorporation, solid-
State 
29
Si MAS NMR experiments were performed. Ga free MBGs (Figure 2) show the resonances 
corresponding to the silicon species Q
4
, Q
3
, Q
2 
and Q
2
Ca (with non-bonding oxygens associated to 
calcium cations). 
1H→29Si CP MAS spectra provide valuable information about the Si environment 
at the MBGs surface. The 
1H→29Si CP spectrum for MBG-58S decreases the intensity of the Q4 
resonances and emphasizes the resonances for Q
3
 and Q
2
 due to the presence of Si-OH groups at the 
MBG surface. The Q
2
 resonance associated to the presence of Ca
2+
 is emphasized in a higher degree, 
pointing out that the MBG surface is enriched in Ca
2+
 with respect to the inner part of the MBG 
walls. On the other hand, MBG-85S does not show Q
2
(Ca
2+
) resonance in the single-pulse MAS 
spectrum and only a weak resonance can be observed in the 
1H→29Si CP experiment. After Ga 
incorporation, both single pulse and 
1H→29Si CP MAS spectra showed very similar results (Figure 
S2 in supporting information). The network connectivity of the different MBGs was calculated from 
the de-convoluted peak areas of single pulse spectra and are shown in Table 4. The results show that 
MBGs with higher Ca contents (MBG-58S and MBG-58SGa) have lower network connectivity 
compared to MBG-85S and MBG-85SGa. Moreover, 
29
Si MAS NMR experiments indicate that the 
connectivity of the silica network is not significantly affected after Ga incorporation.  
To probe the Ga local environment in the Ga-containing MBGs, 
71
Ga solid-state MAS NMR 
experiments were performed at very high magnetic field (20.0 T). As shown in Figure 3, the 
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experimental 
71
Ga central transition (CT) MAS NMR spectra of the MBGs exhibit two resolved 
resonances with asymmetric line shapes characteristic of a distribution of the quadrupolar 
interaction. To account for this distribution, the 
71
Ga MAS NMR line shapes were reconstructed 
according to the Gaussian Isotropic Model (GIM) in which the distribution of the electric field 
gradient is assumed to correspond to a statistical disorder [49,50]. For the two observed resonances, 
the mean 
71
Ga isotropic chemical shifts determined from fits of the experimental spectra are 
characteristic of respectively six-fold (δISO = 47 ppm) and four-fold (δISO = 172 ppm) coordinated Ga 
in silicate environments, thus ruling out interaction between Ga ions and calcium phosphate 
groups[51–53]. This is also supported by the 31P MAS NMR spectra of the MBGs which remain 
similar before and after the Ga
3+
/Ca
2+
 exchange process (see supporting information). For the two 
MBG compositions investigated, the 
71
Ga MAS NMR spectra therefore reveal that the Ga
3+
 cations 
are mainly incorporated in the silicate network as GaO4 units (about 67 and 73% for MBG-58S and 
MBG-85S respectively) and that only a weak amount of them forms GaO6 units (about 33 and 27 % 
for MBG-58S and MBG-85S respectively). This suggests that Ga incorporation into MBG is not 
only related to a Ga/Ca exchange process but also involves the formation of GaO4 units via Ga-O-Si 
covalent bonds. It should also be noted that the observed incorporation of GaO4 units in the silicate 
network requires charge balancing which can be ensured either by Ca
2+
 or H
+
 cations. 
3.2 In vitro bioactivity test 
Figure 4 shows the Ca
2+
 concentration and pH values of SBF as a function of soaking time of the 
different MBGs. Calcium levels (Figure 4.a) increase for all the samples during the first 24 h and, the 
calcium concentration slowly decreases until the end of the assay. Figure 4.b plots the pH evolution 
of SBF as a function of soaking time, showing a decrease of H
+
 concentration in SBF because of the 
ionic exchange with Ca
2+
 from the MBGs.  
The evolution of the MBGs surfaces as a function of soaking time was followed by FTIR 
spectroscopy through. (Figure S4 in supporting information). Before soaking, the MBGs show a 
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weak singlet absorption band at 600 cm
-1
 corresponding to the bending vibrational mode of 
phosphate groups in an amorphous environment, as correspond to P2O5 included in MBGs 
compositions. After 6h in SBF, this band increases the intensity and split into a doublet at 560 and 
610 cm
-1
. The appearance of this doublet is commonly assigned to the formation of an apatite-like 
phase when bioactive glasses are in contact with SBF or similar biomimetic solutions [54]. In the 
case of MBG-58S and MBG-58SGa, an intense band at 1400-1550 cm
-1
 corresponding to the 
stretching vibrational mode of CO3
2-
 groups increases as a function of soaking time, indicating that 
the newly growth phase is a crystalline carbonated hydroxyapatite. This fact is related with the 
different morphology observed for the apatite crystallites in these samples. SEM observations at 
higher magnification (supporting information Figure S6) demonstrate that MBG-58S and MBG-
58SGa develop an apatite phase made up of agglomerated spherical particles composed by very 
small crystallites, whereas MBG-85S and MBG85S-Ga form apatite with flake-shape morphology 
and larger crystallites.  
Besides, the presence of a newly formed apatite like phase was confirmed by SEM (Figure 5), 
indicating that, regardless the Ga presence or absence, the new apatite like phase nucleate and grows 
on these materials.  
3.3 Ga in vitro release 
Prior to put in contact the cells with the MBGs, we analysed the Ga solubility from the materials in 
-MEM (figure S7 in supporting information). After 7 days, Ga(III) concentration in -MEM 
reached 803 M and 71 M for MBG-58SGa and MBG-85SGa, respectively. After 10 days, the 
concentrations of Ga released were 860 M and 86 M for MBG-58SGa and MBG-85SGa, 
respectively. These results indicate that, after this period, MBG-58SGa releases the 40% of the its 
gallium content whereas MBG-85SGa releases only the 12 %. 
 
3.4 Effect of Ga on MC3T3-E1 pre-osteoblast like cells 
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To evaluate Ga effect in osteoblastic bone forming cells, cell culture tests were carried out with 
MC3T3-E1 pre-osteoblast in the presence and absence of the materials for 1, 4 and 7 days. 
Fluorescence microscopy images (Figure 6) show that MC3T3-E1 pre-osteoblast cultured in the 
presence of MBG are flattened and attached to the wells similarly to the cells in absence of materials 
(supporting information Fig S8). The cells show well-developed actin cytoskeletons organized into 
long parallel bundles, together with the nuclei in blue stained with DAPI. The purple bodies 
observed in the images correspond to MBGs particles that absorbed both stains in their mesoporous 
structure. MBG particles, which are in direct contact with MC3T3-E1 pre-osteoblast (Figure S9 in 
supporting information), do not lead to any morphological anomaly of the cytoskeleton.  
Figure 7.a shows the proliferation of MC3T3-E1 in contact with MBGs. In agreement with the 
images observed by confocal microscopy, pre-osteoblast cells exhibit a good proliferative behaviour 
in contact with both, gallium free and gallium containing materials.  
The effect of Ga on the MC3T3-E1 activity and early differentiation was studied by 
measuring the ALP and total protein after 7 days of incubation in contact with the materials (Figure 
7.b). Significant differences in ALP activity were observed by comparing MBGs with and without 
Ga. In this case, MC3T3-E1 expressed higher ALP phosphatase activity when they were cultured in 
the presence of MBG-58SGa and MBG-85SGa, when compared to their Ga-free analogues.  
3.5 Effect of Ga-doped MBGs on osteoclast cells 
First, we measured the effect of the 4 different MBGs on the viability of RAW 264.7 monocytic cells 
stimulated with RANK-L (Figure 8A). Compared to the control, both MBG-58S and MBG-85S 
significantly decreased the viability of RAW 264.7 (respectively 27 and 22 %) but, Ga had no 
supplementary impact. 
To evaluate the antiresorptive capability of Ga doped MBGs, the measurement of TRAP expression 
of mature osteoclasts has been carried out. The evaluation of positive multinucleated stained cells by 
microscopy let know that Ga dramatically affected the viability of mature OC whereas cells were 
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normal when treated with control MBGs (i.e MBG-58S or MBG-85S). This inhibition is more 
pronounced in the case of MBG-85SGa. To quantify Ga effect on the osteoclast differentiation, we 
measured TRAP staining. We have previously demonstrated that TRAP quantification can be 
considered as a reliable marker of osteoclastogenesis [47]. Indeed, a correlation between the TRAP 
content per well and the number of TRAP+ multinucleated cells per well has been observed. Figure 
8B evidences that the presence of Ga in MBG-58SGa and MBG-85SGa, strongly inhibited the 
expression of TRAP as compared to control condition.  
 
4. Discussion 
In this work we propose the incorporation of Ga(III) ions within MBGs as a strategy to improve the 
bone forming capability of these bioceramics. On the assumption that Ga(III) can inhibit 
osteoclastogenesis while fostering osteoblasts early differentiation, we envision that Ga-containing 
MBGs would be excellent bone grafting materials for osteoporotic patients. To understand the 
potential activity of Ga(III) ions over pre-osteoblasts and osteoclasts, we have carried out a deep 
physicochemical study, paying special attention to the Ga local environment in Ga-containing 
MBGs. Our results demonstrate that Ga(III) ions are mainly incorporated as tetrahedral GaO4 units. 
In this sense Ga (III) would covalently contribute as non-soluble species to the network connectivity 
of the SiO2-CaO-P2O5 MBGs. The covalent bonding would be a consequence of the 
polycondensation of [GaO4] units with the [SiO4] tetrahedrons at the surface of MBGs, favoured by 
the alkaline conditions during the Ga incorporation process. This mechanism takes place in both 
MBG-58SGa and MBG-85SGa. Additionally, Ga(III) ions are also incorporated as [GaO6] 
octahedral species, thus acting as network modifiers and would constitute the main fraction of 
soluble Ga in MBGs. The incorporation of GaO6 species occurs by means of Ca (II)-Ga(III) ionic 
exchange with Ca(II) cations of the MBGs. This second incorporation mechanism takes place to a 
higher extent in MBG-58SGa, as this composition contains more soluble Ca (II) ions acting as 
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network modifiers in MBG-58S. During the Ca(II)-Ga(III) exchange, Ca
2+
 cations are released and 
the partial dissolution of MBG-58S takes place. Consequently, an enlargement of the pore size 
occurs, which is reflected in the higher values of pore size distribution observed for MBG-58SGa.  In 
the case of MBG-85SGa, Ca(II)-Ga(III) exchange occurs to a lesser extent due to the smaller amount 
of Ca(II) available as network modifier. It must be highlighted that the presence of P2O5 as 
orthophosphate entraps most of the Ca
2+
 cations in calcium phosphate clusters, as could be observe 
by 
31
P NMR studies and previously reported by our group [26-29]. In addition, the higher silica 
network connectivity of MBG-85S avoids the dissolution of this MBG during Ga(III) incorporation 
and, consequently, the pore size remains almost constant (Table 2). Depending on the composition of 
the MBG, surface area and porosity change differently after gallium incorporation. In the case of 
MBG-58SGa, it proceeds by means of calcium-gallium exchange. This mechanism involves the 
partial dissolution of MBG-58S, thus decreasing the surface area and increasing the pore size. On the 
other hand, MBG-85SGa evidences a higher decrease of surface area while keeping the pore size 
after gallium incorporation. These data point out that gallium mainly incorporates on the outer 
surface of MBG-85S without affecting the inner porous structure by dissolution. These results would 
agree with those obtained by Ga-NMR that indicate that gallium is mainly incorporate on MBG-
85SGa through the polycondensation of [GaO4] units on the surface.  
Despite of the Ca(II) decrease associated to Ga(III) incorporation, Ga-containing MBGs 
exhibit an excellent in vitro bioactive behavior. Both MBG-58SGa and MBG-85SGa developed an 
apatite like-layer on their surface after 6 hours in contact with SBF. This test, although not definitive, 
is indicative of the osseointegration capability of this kind of materials under in vivo conditions [46, 
55]. In this sense, the high surface area and porosity of MBGs would be responsible of the high 
bioactivity, regardless the calcium loss.  
Ga (III) ions do not affect pre-osteoblast proliferation and stimulate the early differentiation 
toward osteoblast phenotype. The increment of ALP activity of pre-osteoblasts in contact with Ga-
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containing MBGs respect to Ga-free MBGs indicate that this ion provides signals to stimulate 
differentiation toward bone forming cells. It must be highlighted that a very small amount of Ga(III) 
in MBG-85SGa is enough to produce a significant increase of this early differentiation marker 
respect to MBG-85S. On the other hand, Ga incorporation in MBGs influences TRAP expression 
suggesting that the presence of Ga disturbs the osteoclastogenesis. These in vitro results are in 
concordance with our previous data relative to the biological effects of Ga in solution and loaded in a 
calcium phosphate matrix [36,56,57]. Interestingly, the activity of Ga has been closely related with 
its capability for being released as soluble species. At physiological pH, most of the dissolved Ga is 
present as gallate, Ga(OH)4
-
 although the pH variability in the different bone compartments can 
modify both, solubility and speciation of Ga. In the case of our MBGs, although Ga solubility is very 
low (specially for MBG85S-Ga) is enough to inhibit osteoclastogenesis. After ten days in -MEM, 
the released gallium reached 70 and 810 molar concentrations for MBG85S-Ga and MBG58S-Ga, 
respectively. Blair et al demonstrated that gallium concentrations between 7-12 molar in vivo and 
around 100 molar in vitro, are enough to promote inhibition of osteoclastogenesis [58]. In this 
sense, both MBGs would be able to supply soluble gallium species to impact on the cultured cells. 
However, it must be highlighted that osteoclast inhibition is more pronounced in the case of MBG-
85SGa, although the amount of Ga released is much lower compared to MBG-58SGa. This fact 
suggests that gallium bonded at the MBG85S-Ga surface is active, similarly to the experiment of 
Hall and Chambers, who demonstrated that bonded gallium to bone remain active [32]. In fact, in the 
case of MBG85S-Ga, gallium is mainly incorporated at the external surface of the MBG85S as 
indicated by the dramatic reduction of textural properties after Ga incorporation (Table 3). Our 
results suggest that, in addition to the solubilized gallium, this element would be also incorporated 
into macrophages in contact with MBG particles, thus inhibiting the differentiation toward osteoclast 
phenotype.  
Conclusions 
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Mesoporous bioactive glasses in the system SiO2-CaO-P2O5-Ga2O3 have been prepared by 
impregnation of Ga(III) on two different SiO2-CaO-P2O5. Ga (III) incorporation proceeds according 
to two different mechanisms: direct condensation within the silica network and ionic exchange with 
Ca (II), resulting in the formation of network formers GaO4 units and network modifiers GaO6. 
The incorporation of Ga within SiO2-CaO-P2O5 MBGs does not inhibit their excellent bioactive 
behavior. 
The presence of Ga in MBGs shows a selective behavior with respect to different cell types. Whereas 
Ga-doped MBGs stimulate the early differentiation of pre-osteoblast towards osteoblastic phenotype, 
our experiments also demonstrate that Ga disturbs the osteoclastogenesis. Interestingly, these effects 
of Ga on bone cells does not require the dissolution of this element. 
Considering the excellent bioactive behavior of SiO2-CaO-P2O5-Ga2O3 based MBGs and their 
selective behavior with respect to osteoblasts and osteoclasts, these bioceramics might be considered 
as excellent bone substitutes for regenerative purposes in osteoporotic patients.  
Acknowledgements 
This study was supported by research grants from the Ministerio de Economía y Competitividad 
(projects MAT2015-64831-R and MAT2016-75611-R AEI/FEDER, UE. M.V.-R. acknowledges 
funding from the European Research Council (Advanced Grant VERDI; ERC-2015-AdG Proposal 
694160).  
  
  
20 
 
References 
[1] X. Yan, C. Yu, X. Zhou, J. Tang, D. Zhao, Highly ordered mesoporous bioactive glasses with 
superior in vitro bone-forming bioactivities, Angew. Chemie. Int. Ed. 43 (2004) 5980–5984.  
[2] X. Yan, X. Huang, C. Yu, H. Deng, Y. Wang, Z. Zhang, S. Qiao, G. Lu, D. Zhao, The in-vitro 
bioactivity of mesoporous bioactive glasses, Biomaterials. 27 (2006) 3396–3403.  
[3] A. López-Noriega, D. Arcos, I. Izquierdo-Barba, Y. Sakamoto, O. Terasaki, M. Vallet-Regí, 
Ordered Mesoporous Bioactive Glasses for Bone Tissue Regeneration, Chem. Mater. 18 
(2006) 3137–3144.  
[4] X. Chen, Y. Zhao, S. Geng, R.J. Miron, Q. Zhang, C. Wu, Y. Zhang, In vivo experimental 
study on bone regeneration in critical bone defects using PIB nanogels/boron-containing 
mesoporous bioactive glass composite scaffold, Int J Nanomedicine. 10 (2015) 839–846.  
[5] N. Cheng, Y. Wang, Y. Zhang, B. Shi, The Osteogenic Potential of Mesoporous 
Bioglasses/Silk and Non-Mesoporous Bioglasses/Silk Scaffolds in Ovariectomized Rats: In 
vitro and In vivo Evaluation, PLoS One. 8 (2013) e81014.  
[6] C. Wu, J. Chang, Mesoporous bioactive glasses: structure characteristics, drug/growth factor 
delivery and bone regeneration application, Interface Focus. 2 (2012) 292–306.  
[7] M. Vallet-regí, D. Arcos, Mesoporous Materials for Biomedical applications, in: P. J. Pannone 
(Ed), Trends in Biomaterials Research, Nova Science Publishers, Inc, (2007) 109–142. 
[8] N. Gómez-Cerezo, I. Izquierdo-Barba, D. Arcos, M. Vallet-Regí, Tailoring the biological 
response of mesoporous bioactive materials, J. Mater. Chem. B. (2015) 3810–3819.  
[9] J.R. Jones, Reprint of: Review of bioactive glass: From Hench to hybrids, Acta Biomater. 23 
(2015) 53–82. 
  
21 
 
[10] L.L. Hench, I.D. Xynos, J.M. Polak, Bioactive glasses for in situ tissue regeneration, J. 
Biomater. Sci. Polym. Ed. 15 (2004) 543–562.  
[11] I.D. Xynos, A.J. Edgar, L.D.K. Buttery, L.L. Hench, J.M. Polak, Gene-expression profiling of 
human osteoblasts following treatment with the ionic products of Bioglass®45S5 dissolution, 
J. Biomed. Mater. Res. 55 (2001) 151–157.  
[12] I.D. Xynos, M.V.J. Hukkanen, J.J. Batten, L.D. Buttery, L.L. Hench, J.M. Polak, Bioglass 
®45S5 Stimulates Osteoblast Turnover and Enhances Bone Formation In Vitro: Implications 
and Applications for Bone Tissue Engineering, Calcif. Tissue Int. 67 (2000) 321–329.  
[13] I. Izquierdo-Barba, D. Arcos, Y. Sakamoto, O. Terasaki, A. López-Noriega, M. Vallet-Regí 
High-Performance Mesoporous Bioceramics Mimicking Bone Mineralization, Chem. Mater.,. 
20 (2008) 3191–3198. 
[14] C. Wu, J. Chang, Multifunctional mesoporous bioactive glasses for effective delivery of 
therapeutic ions and drug/growth factors, J. Control. Release. 193 (2014) 282–295.  
[15] Y. Li, Y.Z. Liu, T. Long, X. Bin Yu, T.T. Tang, K.R. Dai, B. Tian, Y.P. Guo, Z.A. Zhu, 
Mesoporous bioactive glass as a drug delivery system: Fabrication, bactericidal properties and 
biocompatibility, J. Mater. Sci. Mater. Med. 24 (2013) 1951–1961.  
[16] M. Zhu, J. Shi, Q. He, L. Zhang, F. Chen, Y. Chen, An emulsification-solvent evaporation 
route to mesoporous bioactive glass microspheres for bisphosphonate drug delivery, J. Mater. 
Sci. 47 (2012) 2256–2263.  
[17] F. Wang, D. Zhai, C. Wu, J. Chang, Multifunctional mesoporous bioactive glass/upconversion 
nanoparticle nanocomposites with strong red emission to monitor drug delivery and stimulate 
osteogenic differentiation of stem cells, Nano Res. 9 (2016) 1193–1208.  
  
22 
 
[18] L. Polo, N. Gómez-Cerezo, E. Aznar, J. Vivancos, F. Sancenón, D. Arcos, M. Vallet-Regí, R. 
Martínez-Máñez, Molecular gates in mesoporous bioactive glasses for the treatment of bone 
tumors and infection, Acta Biomater. 50 (2017) 114–126.  
[19] H.M. Lin, W.K. Wang, P.A. Hsiung, S.G. Shyu, Light-sensitive intelligent drug delivery 
systems of coumarin-modified mesoporous bioactive glass, Acta Biomater. 6 (2010) 3256–
3263.  
[20] P. Han, C. Wu, J. Chang, Y. Xiao, The cementogenic differentiation of periodontal ligament 
cells via the activation of Wnt/a-catenin signalling pathway by Li + ions released from 
bioactive scaffolds, Biomaterials. 33 (2012) 6370–6379.  
[21] Y. Zhang, L. Wei, J. Chang, R.J. Miron, B. Shi, S. Yi, C. Wu, Strontium-incorporated 
mesoporous bioactive glass scaffolds stimulating in vitro proliferation and differentiation of 
bone marrow stromal cells and in vivo regeneration of osteoporotic bone defects, J. Mater. 
Chem. B. 1 (2013) 5711.  
[22] J. Ye, J. He, C. Wang, K. Yao, Z. Gou, Copper-containing mesoporous bioactive glass 
coatings on orbital implants for improving drug delivery capacity and antibacterial activity, 
Biotechnol. Lett. 36 (2014) 961–968.  
[23] C. Wu, Y. Zhou, W. Fan, P. Han, J. Chang, J. Yuen, M. Zhang, Y. Xiao, Hypoxia-mimicking 
mesoporous bioactive glass scaffolds with controllable cobalt ion release for bone tissue 
engineering., Biomaterials. 33 (2012) 2076–85.  
[24] C. Wu, R. Miron, A. Sculean, S. Kaskel, T. Doert, R. Schulze, Y. Zhang, Proliferation, 
differentiation and gene expression of osteoblasts in boron-containing associated with 
dexamethasone deliver from mesoporous bioactive glass scaffolds, Biomaterials. 32 (2011) 
7068–7078.  
  
23 
 
[25] R. Mathew, P.N. Gunawidjaja, I. Izquierdo-barba, K. Jansson, A. García, D. Arcos, M. Vallet-
regí, M. Ed, Solid-State 31 P and 1 H NMR Investigations of Amorphous and Crystalline 
Calcium Phosphates Grown Biomimetically From a Mesoporous Bioactive Glass, J. Phys. 
Chem. (2011) 0–10.  
[26] E. Leonova, I. Izquierdo-Barba, D. Arcos, A. López-Noriega, N. Hedin, M. Vallet-Regí, M. 
Edén, Multinuclear Solid-State NMR Studies of Ordered Mesoporous Bioactive Glasses, J. 
Phys. Chem. C. 112 (2008) 5552–5562.  
[27] P.N. Gunawidjaja, R. Mathew, A.Y.H. Lo, I. Izquierdo-Barba, A. García, D. Arcos, M. Vallet-
Regí, M. Edén, Local structures of mesoporous bioactive glasses and their surface alterations 
in vitro: inferences from solid-state nuclear magnetic resonance, Phil. Trans. R. Soc. A. 370 
(2012) 1376–1399.  
[28] R. Mathew, C. Turdean-Ionescu, B. Stevensson, I. Izquierdo-Barba, A. García, D. Arcos, M. 
Vallet-Regí, M. Edén, Direct probing of the phosphate-ion distribution in bioactive silicate 
glasses by solid-state NMR: Evidence for transitions between random/clustered scenarios, 
Chem. Mater. 25 (2013) 1877–1885.  
[29] A. García, M. Cicuéndez, I. Izquierdo-Barba, D. Arcos, M. Vallet-Regi, Essential role of 
calcium phosphate heterogeneities in 2D-hexagonal and 3D-cubic SiO2-CaO-P2O5 
mesoporous bioactive glasses, Chem. Mater. 21 (2009) 5474–5484.  
[30] A. Philippart, N. Gómez-Cerezo, D. Arcos, A.J. Salinas, E. Boccardi, M. Vallet-Regi, A.R. 
Boccaccini, Novel ion-doped mesoporous glasses for bone tissue engineering: Study of their 
structural characteristics influenced by the presence of phosphorous oxide, J. Non. Cryst. 
Solids. 455 (2017) 90-97.  
[31] P. Ridefelt, E. Gylfe, G. Akerström, J. Rastad, Effects of the antihypercalcemic drugs Ga 
  
24 
 
nitrate and pamidronate on hormone release of pathologic human parathyroid cells, Surgery. 
117 (1995) 56–61.  
[32] T.J. Hall, T.J. Chambers, Ga inhibits bone resorption by a direct effect on osteoclasts, Bone 
Miner. 8 (1990) 211–216.  
[33] R.S. Bockman, A.L. Boskey, N.C. Blumenthal, N.W. Alcock, R.P. Warrell, Ga increases bone 
calcium and crystallite perfection of hydroxyapatite, Calcif. Tissue Int. 39 (1986) 376–381.  
[34] M.A. Repo, R.S. Bockman, F. Betts, A.L. Boskey, N.W. Alcock, R.P. Warrell  Jr., Effect of 
Ga on bone mineral properties, Calcif. Tissue Int. 43 (1988) 300–306. 
[35] R.P. Warrell, Ga nitrate for the treatment of bone metastases, Cancer. 80 (1997) 1680–1685.  
[36] E. Verron, M. Masson, S. Khoshniat, L. Duplomb, Y. Wittrant, M. Baud’Huin, Z. Badran, B. 
Bujoli, P. Janvier, J.C. Scimeca, J.M. Bouler, J. Guicheux, Ga modulates osteoclastic bone 
resorption in vitro without affecting osteoblasts, Br. J. Pharmacol. 159 (2010) 1681–1692.  
[37] E. Verron, J.M. Bouler, J.C. Scimeca, Ga as a potential candidate for treatment of 
osteoporosis, Drug Discov Today. 17 (2012) 1127–1132. 
[38] C. Mellier, F. Fayon, F. Boukhechba, E. Verron, M. Leferrec, G. Montavon, J. Lesoeur, V. 
Schnitzler, D. Massiot, P. Janvier, O. Gauthier, J. Bouler, B. Bujoli, Design and properties of 
novel Ga-doped injectable apatitic cements, Acta Biomater. 24 (2015) 322–332.  
[39] S. Shruti, F. Andreatta, E. Furlani, E. Marin, S. Maschio, L. Fedrizzi, Cerium, Ga and zinc 
containing mesoporous bioactive glass coating deposited on titanium alloy, Appl. Surf. Sci. 
378 (2016) 216–223.  
[40] S. Shruti, A.J. Salinas, G. Lusvardi, G. Malavasi, L. Menabue, M. Vallet-Regi, Mesoporous 
bioactive scaffolds prepared with cerium-, Ga- and zinc-containing glasses, Acta Biomater. 9 
  
25 
 
(2013) 4836–4844.  
[41] S. Shruti, A.J. Salinas, E. Ferrari, G. Malavasi, G. Lusvardi, A.L. Doadrio, L. Menabue, M. 
Vallet-Regi, Curcumin release from cerium, Ga and zinc containing mesoporous bioactive 
glasses, Microporous Mesoporous Mater. 180 (2013) 92–101.  
[42] A.J. Salinas, S. Shruti, G. Malavasi, L. Menabue, M. Vallet-Regí, Substitutions of cerium, Ga 
and zinc in ordered mesoporous bioactive glasses, Acta Biomater. 7 (2011) 3452–3458.  
[43] S. Pourshahrestani, E. Zeimaran, N. Adib Kadri, N. Gargiulo, S. Samuel, S.V. Naveen, T. 
Kamarul, M.R. Towler, Ga-containing mesoporous bioactive glass with potent hemostatic 
activity and antibacterial efficacy, J. Mater. Chem. B. 4 (2016) 71–86.  
[44] C.J. Brinker, Y. Lu, A. Sellinger, H. Fan, Evaporation-Induced Self-Assembly: 
Nanostructures Made Easy, Adv. Mater. 11 (1999) 579–585.  
[45] B.M. Fung, A.K. Khitrin, K. Ermolaev, An Improved Broadband Decoupling Sequence for 
Liquid Crystals and Solids, J. Magn. Reson. 142 (2000) 97–101. 
[46] T. Kokubo, H. Kushitani, S. Sakka, T. Kitsugi, T. Yamamuro, Solutions able to reproduce in 
vivo surface-structure changes in bioactive glass-ceramic, J. Biomed. Mater. Res. 24 (1990) 
721–34. 
[47]  I. Strazic-Geljic, I. Guberovic, B. Didak, H. Schmid-Antomarchi, A. Schmid-Alliana, F. 
Boukhechba, J.-M. Bouler, J.-C. Scimeca, E. Verron, Ga, a promising candidate to disrupt the 
vicious cycle driving osteolytic metastases, Biochem. Pharmacol. 116 (2016) 11–21. 
[48]  D. Zhao, Q. Huo, J. Feng, B.F. Chmelka, G.D. Stucky, Nonionic triblock and star diblock 
copolymer and oligomeric surfactant syntheses of highly ordered, hydrothermally stable, 
mesoporous silica structures. J. Am. Chem. Soc. 120 (1998) 6024-6036  
  
26 
 
[49] B. Bureau, G. Silly, J. Buzaré, C. Legein, D. Massiot, From crystalline to glassy Ga fluoride 
materials: an NMR study of 69Ga and 71Ga quadrupolar nuclei, Solid State Nucl. Magn. 
Reson. 14 (1999) 181–190.  
[50] G. Czjzek, J. Fink, F. Götz, H. Schmidt, J.M.D. Coey, J.-P. Rebouillat, A. Liénard, Atomic 
coordination and the distribution of electric field gradients in amorphous solids, Phys. Rev. B. 
23 (1981) 2513–2530.  
[51] C.-F. Cheng, H. He, W. Zhou, J. Klinowski, J.A.S. Gonçalves, L.F. Gladden, Synthesis and 
Characterization of the Gallosilicate Mesoporous Molecular Sieve MCM-41, J. Phys. Chem. 
100 (1996) 390–396. 
[52] V. Montouillout, C.M. Morais, A. Douy, F. Fayon, D. Massiot, Towards a better description 
of gallo-phosphate materials in solid state NMR: 1D and 2D correlation studies, Magn. Reson. 
Chem. 44 (2006) 770-775. 
[53] C. Mellier, F. Fayon, V. Schnitzler, P. Deniard, M. Allix, S. Quillard, D. Massiot, J.-M. 
Bouler, B. Bujoli, P. Janvier, Characterization and Properties of Novel Ga-Doped Calcium 
Phosphate Ceramics, Inorg. Chem. 50 (2011) 8252–8260. 
[54]  A.L.B. MaÇon, T.B. Kim, E.M. Valliant, K. Goetschius, R. K. Brow , D.E. Day, A. Hoppe, A. 
R. Boccaccini, I.Y. Kim, C. Ohtsuki, T. Kokubo, A. Osaka, M. Vallet-Regí, D. Arcos, L. 
Fraile, A.J. Salinas, A.V. Teixeira, Y. Vueva, R. M. Almeida, M. Miola, C. Vitale-Brovarone,  
E. Verné, W. Höland, J. R. Jones. A unified in vitro evaluation for apatite-forming ability of 
bioactive glasses and their variants, J Mater Sci: Mater Med. 26 (2015) 115-124.  
[55] M. Bohner, J. Lemaitre, Can bioactivity be tested in vitro with SBF solution?, Biomaterials. 
30 (2009) 2175–2179.  
 
  
27 
 
[56] I. Strazic Geljic, N. Melis, F. Boukhechba, S. Schaub, C. Mellier, P. Janvier, J.-P. Laugier, J.-
M. Bouler, E. Verron, J.-C. Scimeca, Ga enhances reconstructive properties of a calcium 
phosphate bone biomaterial, J. Tissue Eng. Regen. Med. 12 (2018) e854-e866. 
[57] E. Verron, A. Loubat, G.F. Carle, C. Vignes-Colombeix, I. Strazic, J. Guicheux, N. Rochet, 
J.M. Bouler, J.C. Scimeca, Molecular effects of Ga on osteoclastic differentiation of mouse 
and human monocytes, Biochem. Pharmacol. 83 (2012) 671–679. 
[58] H.C. Blair, S.L. Teitelbaum, H.L. Tan, P.H. Schlesinger, Reversible inhibition of osteoclastic 
activity by bone-bound gallium (III). J. Cell Biochem, 48 (1992) 401-410 
 
  
  
28 
 
Figure captions 
Figure 1. Low angle XRD patterns (left) and TEM images of the different MBGs synthesized 
(right). 
Figure 2. Solid-state 
29
Si single-pulse (left) and cross-polarization (right) MAS NMR spectra of Ga 
free MBGs.  
Figure 3: 
71
Ga solid state NMR MAS spectra of MBG-58SGa and MBG-85SGa and their 
deconvolution.  
Figure 4. Ionic dissolution in different media. (a) Ca
2+ 
concentration and (b) pH changes as a 
function of soaking time in SBF.  
Figure 5. SEM micrographs of the MBGs before (left) and after soaking in SBF for 24 hours (right) 
Figure 6. Fluorescence microscopy images of MC3T3-E1 after 4 days in contact with MBGs. Some  
MBG particles are observed in purple and delimited into a white line. Control image shows MC3T3-
E1 after 4 days in the absence of material. 
Figure 7. (A) Proliferation of MC3T3-E1 pre-osteoblast like cells at 1, 4 and 7 days of culture in 
contact with the different MBGs synthesized. Statistical significance: *p < 0.05 (4 days vs 1 day) #p 
< 0.01  (7 days vs 4 days). (B) ALP activity of MC3T3-E1 pre-osteoblast like cells after 7 days of 
culture in contact with the different MBGs synthesized. Statistical significance: **p < 0.05 
Figure 8. (A) Viability of  Raw  264,7 mouse monocyte cells  after 4 days of culture with 20 nM 
RANKL and in contact with 10 mg/ml of the different MBGs. (B) Effect of MBGs on the TRAP 
expression of mature OC. Cells were cultured for 4 days in presence of 20 nM RANKL. Then TRAP 
dosage of cellular extracts was performed, and optical density was read at 562 nm. Results were 
normalized according to control condition. * p<0.05, statistically significant compared to control 
condition. 
  
29 
 
  
  
30 
 
 
  
  
31 
 
 
  
  
32 
 
 
  
  
33 
 
 
  
  
34 
 
 
  
  
35 
 
 
  
  
36 
 
 
  
  
37 
 
 
  
  
38 
 
Table 1. Amounts of reagents used for the synthesis of the MBGs.  
 
Table 2. Textural parameters obtained by N2 adsorption porosimetry for the MBGs synthesized. 
Standard deviations are indicated in brackets.  
Sample Surface area 
(m
2
·g
-1
) 
Pore volume 
(cm
3
·g
-1
) 
Pore size 
(nm) 
MBG-58S 158.2 
(±13.1) 
0.14 
(±0.05) 
5.8 
(±0.9) 
MBG-58SGa 104.9 
(±0.6) 
0.23 
(±0.01) 
9.8 
(±0.6) 
MBG-85S 287.5 
(±1.1) 
0.29 
(±0.04) 
5.4 
(±0.6) 
MBG-85SGa 87.0 
(±0.1) 
0.12 
(±0.07) 
5.5 
(±0.7) 
 
Table 3. Theoretical and experimental chemical compositions determined by XRF spectroscopy for 
the MBGs studied. Error values are indicated in brackets 
Sample Theoretical composition 
(% mol)
a
 
Experimental composition 
(% mol)
b
 
MBG-58S 58 SiO2 –37 CaO –5 P2O5 55.5 SiO2 - 36.6 CaO - 7.9 P2O5 
(0.20)         (0.15)        (0.11) 
MBG-58SGa 58 SiO2 –31 CaO –5 P2O5 -6 Ga2O3 55.8 SiO2 -29.5 CaO -7.7 P2O5 -7.0 Ga2O3 
(0.25)        (0.18)        (0.1)        (0.085)  
MBG-85S 85 SiO2 –10 CaO –5 P2O5 85.2 SiO2 - 10.6 CaO - 4.2 P2O5 
(0.45)         (0.13)        (0.085) 
MBG-85SGa 85 SiO2 -8.4CaO- 5P2O5- 1.6 Ga2O3 83.5 SiO2 -10.2 CaO -4.3 P2O5 -2.0 Ga2O3 
(0.62)        (0.081)      (0.002)    (0.05) 
a
 Assuming that Ca
2+
 is substituted by Ga
3+
; 
b
 Chemical composition determined by EDX 
spectroscopy 
Sample TEOS (g) TEP (g) Ca(NO3)2·6H2O (g) Ga(NO3)3·4H2O (g) 
MBG-58S 3.49 0.51 2.47 - 
MBG-58SGa 3.49 0.51 2.47 0.1 
MBG-85S 3.70 0.34 0.49 - 
MBG-85SGa 3.70 0.34 0.49 0.026 
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Table 4. Relative peak areas and network connectivity (NC) of silica in MBGs, obtained by Solid-
State Single Pulse 
29
Si MAS NMR. Errors values are included in brackets  
Sample Q
4
 Q
3
 Q
2
 Q
2
 (X
n+
)
a
 N.C 
MBG-58S 52.8 
(0.47) 
28.9 
(0.86) 
13.3 
(0.85) 
6.0 
(0.78) 
3.35 
MBG-58SGa 30.2 
(0.34) 
41.9 
(0.28) 
18.4 
(0.32) 
9.4 
(0.22) 
3.37 
MBG-85S 73.5 
(0.58) 
22.1 
(0.83) 
4.4 
(0.15) 
- 
3.69 
MBG-85SGa 70.3 
(0.25) 
24.2 
(0.19) 
5.6 
(0.04) 
- 
3.64 
a
 Associated to Ca
2+
 and/or Ga
3+ 
cations  
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STATEMENT OF SIGNIFCANCE 
Osteoporosis is the most prevalent bone disease affecting millions of patients every year. However, 
there is a lack of bone grafts specifically designed for the treatment of bone defects occurred because 
of osteoporotic fractures. The consequence is that osteoporotic bone defects are commonly treated 
with the same biomaterials intended for high quality bone tissue. In this work we have prepared 
mesoporous bioactive glasses doped with gallium, demonstrating osteoinductive capability by 
promoting the differentiation of pre-osteoblast toward osteoblasts and partial inhibition of 
osteoclastogenesis. Through a deep study of the local environment of gallium within the mesoporous 
matrix, this work shows that gallium release is not required to produce this effect on osteoblasts and 
osteoclasts. In this sense, the presence of this element at the surface of the mesoporous bioactive 
glasses would be enough to locally promote bone formation while reducing bone resorption. 
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